Frank D. Lee is Director of Bausch Health Companies Inc.. Currently has a direct ownership of 73,795 shares of BHC, which is worth approximately $463,432. The most recent transaction as insider was on Aug 21, 2025, when has been sold 15,912 shares (Common Shares, no par value) at a price of $7.66 per share, resulting in proceeds of $121,885. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.8K
0% 3M change
108.7% 12M change
Total Value Held $463,432

Frank D. Lee Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2025
SELL
Open market or private sale
$121,885 $7.66 p/Share
15,912 Reduced 17.74%
73,795 Common Shares, no par ...
May 16 2025
BUY
Grant, award, or other acquisition
-
54,347 Added 37.73%
89,707 Common Shares, no par ...
May 17 2024
BUY
Grant, award, or other acquisition
-
35,360 Added 50.0%
35,360 Common Shares, no par ...

Also insider at

FMTX
Forma Therapeutics Holdings, Inc. Healthcare
BOLT
Bolt Biotherapeutics, Inc. Healthcare
PCRX
Pacira BioSciences, Inc. Healthcare
FDL

Frank D. Lee

Director
Watertown, MA

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC